SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001280600-18-000063
Filing Date
2018-10-30
Accepted
2018-10-30 16:13:05
Documents
64
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xlrn-20180930x10q.htm 10-Q 854857
2 EXHIBIT 31.1 xlrn-20180930xexhibit311.htm EX-31.1 12285
3 EXHIBIT 31.2 xlrn-20180930xexhibit312.htm EX-31.2 12340
4 EXHIBIT 32.1 xlrn-20180930xexhibit321.htm EX-32.1 7825
  Complete submission text file 0001280600-18-000063.txt   5121143

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT xlrn-20180930.xml EX-101.INS 1154776
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xlrn-20180930.xsd EX-101.SCH 44778
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xlrn-20180930_cal.xml EX-101.CAL 59278
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xlrn-20180930_lab.xml EX-101.LAB 539158
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xlrn-20180930_pre.xml EX-101.PRE 304895
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xlrn-20180930_def.xml EX-101.DEF 202202
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36065 | Film No.: 181147092
SIC: 2836 Biological Products, (No Diagnostic Substances)